Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.

作者: Paul Basset , Akiko Okada , Marie-Pierre Chenard , Rama Kannan , Isabelle Stoll

DOI: 10.1016/S0945-053X(97)90028-7

关键词: Cancer cellCell biologyContext (language use)Stromal cellCancerExtracellularCell surface receptorBiologyMatrix metalloproteinaseExtracellular matrix

摘要: The matrix metalloproteinases (MMPs) are extracellular zinc-enzymes implicated in a number of physiological and pathological tissue remodeling processes, including cancer progression. For long time they have been thought to be produced by malignant cells specifically contribute tumor invasion, through their ability degrade components. However, studies performed over the last few years demonstrated that proteinases progression human carcinomas, most MMPs, fact predominantly expressed stromal not cells. Furthermore, membrane receptors, activators and/or binding sites for some these also found associated with These findings, together observation MMPs can cleave molecules controlling growth factor activities, suggest role during is limited facilitating cell invasion alone but likely participate other aspects phenotype. should regarded as pan-regulators neoformation characteristic tumors, which includes both epithelial expansion stroma formation. In this context, synthetic MMP inhibitors presently designed lead development new generation anticancer agents additional beneficial properties compared existing cytotoxic used treatment malignancies.

参考文章(51)
L. M. Matrisian, W. H. Rodgers, R. A. Jensen, K. J. Heppner, Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. American Journal of Pathology. ,vol. 149, pp. 273- 282 ,(1996)
Jennifer A. Byrne, Catherine Tomasetto, Nicolas Rouyer, Jean-Pierre Bellocq, Marie-Christine Rio, Paul Basset, The Tissue Inhibitor of Metalloproteinases-3 Gene in Breast Carcinoma: Identification of Multiple Polyadenylation Sites and a Stromal Pattern of Expression Molecular Medicine. ,vol. 1, pp. 418- 427 ,(1995) , 10.1007/BF03401579
Richard Poulsom, William G. Stetler-Stevenson, Rosemary E. Jeffery, Patricia A. Wright, Len Rogers, Massimo Pignatelli, Massimo Pignatelli, Gordon W H Stamp, Gordon W H Stamp, Janet M. Longcroft, Lance A. Liotta, Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. American Journal of Pathology. ,vol. 141, pp. 389- 396 ,(1992)
M J Duffy, Proteases as prognostic markers in cancer Clinical Cancer Research. ,vol. 2, pp. 613- 618 ,(1996)
J L Fowlkes, J J Enghild, K Suzuki, H Nagase, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. Journal of Biological Chemistry. ,vol. 269, pp. 25742- 25746 ,(1994) , 10.1016/S0021-9258(18)47310-3
Lynn M. Matrisian, Jean P. Witty, Ken J. Newell, Susan McDonnell, Paul Cannon, Marc Navre, Robert J. Tressler, Modulation of Matrilysin Levels in Colon Carcinoma Cell Lines Affects Tumorigenicity in Vivo Cancer Research. ,vol. 54, pp. 4805- 4812 ,(1994)
Eiko Ohuchi, Hidehiro Nomura, Hiroshi Sato, Motoharu Seiki, Yasunori Okada, Kazushi Imai, Yutaka Fujii, Takanori Aoki, Membrane-Type Matrix Metalloproteinase 1 Is a Gelatinolytic Enzyme and Is Secreted in a Complex with Tissue Inhibitor of Metalloproteinases 2 Cancer Research. ,vol. 56, pp. 2707- 2710 ,(1996)
Clavel C, Murphy G, Cockett M, Girod de Bentzmann S, Polette M, Birembaut P, Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion & Metastasis. ,vol. 13, pp. 31- ,(1993)
Alberto M. Pendás, Carlos López-Otín, Xose S. Puente, Elena Llano, Gloria Velasco, Molecular Cloning of a Novel Membrane-type Matrix Metalloproteinase from a Human Breast Carcinoma Cancer Research. ,vol. 56, pp. 944- 949 ,(1996)